US pharmaceutical firm Lilly is re-entering the infectious diseases market in a big way with the acquisition of three ...
The drugmaker said it would spend up to $4 billion to acquire small companies exploring vaccines for shingles, Epstein-Barr ...
Production of an experimental Ebola vaccine from the developers of a Covid-19 shot is expected to begin soon, with animal studies underway as researchers race to bring a much-needed tool to the ...
Scientists said the vaccine candidate targeting the Bundibugyo Ebolavirus strain is progressing rapidly, with clinical-grade ...
With no approved vaccine for the fast-growing Ebola outbreak in the DRC, experts weigh testing one with unknown protection.
The vaccine development news offers fresh hope as the deadly outbreak in the Democratic Republic of Congo and Uganda ...
I n December 2020, mRNA vaccines leapt into the limelight as a response to the COVID-19 pandemic. To date, millions of people ...
India can boost Ebola vaccine, antibody development through WHO lab network, ICMR: Ex-WHO Chief Scientist ...
Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising so far, but a finished product isn't likely coming any time soon.
The team are working on testing the ChAdOx1 BDBV vaccine, a type of viral-vector vaccine that has been previously used in the ...
Immunization is one of the most effective health interventions we can make. Every year vaccination programmes save millions of lives. They have helped eradicate diseases like smallpox – a deadly virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results